Novel 5-carboxy-8-HQ based histone demethylase JMJD2A inhibitors: Introduction of an additional carboxyl group at the C-2 position of quinoline

Taotao Feng, Dongdong Li, Hai Wang, Jian Zhuang, Fang Liu, Qichao Bao, Yonghua Lei, Weilin Chen, Xiaojin Zhang, Xiaoli Xu, Haopeng Sun, Qidong You, Xiaoke Guo

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

A series of JMJD2A inhibitors had been designed by analyzing the binding mode of 5-carboxy-8-hydroxyquinoline (5-carboxy-8-HQ) with JMJD2A. The inhibitory activity of the synthesized compounds against JMJD2A was determined, followed by docking simulations to understand the structure eactivity relationships. Compounds with potent JMJD2A inhibitory activity demonstrated outstanding selectivity for JMJD2A over PHD2. Several potent compounds were selected to evaluate their antiproliferative activity on tumor cell lines. Among them, compound 6p displayed the best antiproliferative activity. Based on these in vitro biological data, seven compounds were chosen to determine their physicochemical properties. Compound 6p displayed good aqueous solubility and better permeability than 5-carboxy-8-HQ. Our data recognized that compound 6p could be considered as a starting point for development of new JmjC inhibitors.

Original languageEnglish (US)
Pages (from-to)145-155
Number of pages11
JournalEuropean journal of medicinal chemistry
Volume105
DOIs
StatePublished - Nov 13 2015
Externally publishedYes

Keywords

  • 5-Carboxy-8-hydroxyquinoline
  • Anti-tumor
  • JMJD2A inhibitors
  • Physicochemical properties

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Novel 5-carboxy-8-HQ based histone demethylase JMJD2A inhibitors: Introduction of an additional carboxyl group at the C-2 position of quinoline'. Together they form a unique fingerprint.

Cite this